The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Impaired Platelet Production of Nitric Oxide Predicts Presence of Acute Coronary Syndromes
Abstract
Background—Thrombus formation within a coronary vessel is the acute precipitating event in most acute coronary syndromes. Recently, constitutive nitric oxide synthase (cNOS) has been identified in human platelets, and platelet-derived nitric oxide has been shown to inhibit platelet recruitment after aggregation. However, its role in regulating platelet responses under normal or pathologic conditions has not yet been elucidated. Methods and Results—We examined nitric oxide (NO) production by platelets isolated from 87 patients undergoing coronary angiography, 37 with stable angina and 50 with unstable angina or a myocardial infarction within 2 weeks. After stimulation with 5 μmol/L ADP, platelet aggregation and NO production were simultaneously measured with an NO-selective microelectrode adapted for use in a standard platelet aggregometer. Mean (±SEM) platelet-derived NO production was 1.78±0.36 pmol/10 8 and 0.26±0.05 pmol/10 8 platelets in coronary patients with stable angina and acute coronary syndromes, respectively (P=0.0001). By logistic regression analysis, heparin treatment (odds ratio 6.6, CI 1.9 to 22.8,P=0.003), lower platelet-NO production (odds ratio 4.0, CI 1.3 to 11.5,P=0.01), and extent of atherosclerosis (odds ratio 1.5, CI 1.1 to 2.0,P=0.02) were independent predictors of an acute coronary syndrome. In the subset of patients with angiographic evidence of atherosclerosis (n=83), logistic regression demonstrated that platelet NO production (odds ratio 3.9, CI 1.3 to 11.1,P=0.01) and heparin treatment (odds ratio 6.4, CI 1.9 to 22.0,P=0.004) were independent predictors of an acute coronary syndrome, whereas extent of atherosclerosis was not. Conclusions—In summary, aggregating platelets from patients with acute coronary syndromes produce less NO. Since platelet aggregation and thrombus formation are implicated in unstable angina and myocardial infarction, impaired platelet-derived NO production may contribute to the development of acute coronary syndromes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1994) · New England Journal of Medicine · doi:10.1056/nejm199404143301501 · Cited by 4,737
Thrombosis and Acute Coronary-Artery Lesions in Sudden Cardiac Ischemic Death
Davies, M. J., & Thomas, A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198405033101801 · Cited by 1,694 · cited 1×
“140 mg/dL or treatment with insulin or an oral hypoglycemic agent), (4) clinical history of hypertension (blood pressure.”
BackgroundPlatelet Activation in Unstable Coronary Disease
Fitzgerald, D. J., Roy, L., Catella, F., & FitzGerald, G. A. (1986) · New England Journal of Medicine · doi:10.1056/nejm198610163151602 · Cited by 1,141
Falk, E. (1983) · Heart · doi:10.1136/hrt.50.2.127 · Cited by 1,012 · cited 1×
“A research nurse identified the presence of the following risk factors: (1) age, (2) male sex, (3) clinical history of diabetes (fasting blood glucose.”
BackgroundThe role of nitric oxide and cGMP in platelet adhesion to vascular endothelium
Radomski, M. W., Palmer, R. M. J., & Moncada, S. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(87)80299-1 · Cited by 746
Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis.
Freedman, J. E., Loscalzo, J., Benoit, S. E., Valeri, C. R., Barnard, M. R., & Michelson, A. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118522 · Cited by 171 · cited 1×
“In addition, we have shown that the antioxidant enzyme glutathione peroxidase potentiates the inhibition of platelet function by NO through metabolism of reactive oxygen species(45) and that impairment of this process can lead to a clinical thrombotic disorder.(46) Impairment of endothelium-derived nitric oxide has be…”
BackgroundSelf-citation
Cited by
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Self-citationEndothelial Function: A Critical Determinant in Atherosclerosis?
Landmesser, U., Hornig, B., & Drexler, H. (2004) · Circulation · doi:10.1161/01.cir.0000129501.88485.1f · Cited by 851
Nitric Oxide Insufficiency, Platelet Activation, and Arterial Thrombosis
Loscalzo, J. (2001) · Circulation Research · doi:10.1161/hh0801.089861 · Cited by 612
Self-citationThe role of nitric oxide in cardiovascular diseases
NASEEM, K. (2005) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2004.09.003 · Cited by 557
Freedman, J. E., Parker, C., Li, L., Perlman, J. A., Frei, B., Ivanov, V., Deak, L. R., Iafrati, M. D., & Folts, J. D. (2001) · Circulation · doi:10.1161/01.cir.103.23.2792 · Cited by 475
Self-citation
Metadata
- Authors
- Freedman, J. E., Ting, B., Hankin, B., Loscalzo, J., Keaney, J. F., & Vita, J. A.
- Venue
- Circulation
- Published
- 1998-10-13
- Volume
- 98
- Issue
- 15
- Pages
- 1481-1486
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2154480952
- Cited by
- 172
- References
- 6
- FWCI
- 6.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.